MRP ₹1130.5
(Inclusive of all Taxes)
₹169.6 Cashback (15%)
Provide Delivery Location
About Eltropag 25 mg Tablet
Eltropag 25 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltropag 25 mg Tablet is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.
Eltropag 25 mg Tablet contains 'Eltrombopag', which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone, stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Eltropag 25 mg Tablet works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltropag 25 mg Tablet helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.
In some cases, Eltropag 25 mg Tablet can cause common side effects like nausea, diarrhea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you have any allergic reactions to Eltropag 25 mg Tablet or any other medicines before starting Eltropag 25 mg Tablet. Consult the doctor if you are pregnant or planning to conceive. Eltropag 25 mg Tablet is not indicated for use in breastfeeding since it passes into the breast milk.
Uses of Eltropag 25 mg Tablet
Eltropag 25 mg Tablet is used in the treatment of low platelet count (thrombocytopenia) in various blood-related disorders. The detailed uses of Eltropag 25 mg Tablet are as follows:

Have a query?
Directions for Use
Key Benefits
How Eltropag 25 mg Tablet Works
Storage
What if I have taken an overdose of Eltropag 25 mg Tablet
Drug Warnings
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXPERIN HEALTHCARE
₹267.5
(₹9.55 per unit)
RXCipla Ltd
₹458.5
(₹58.96 per unit)
RXGlenmark Pharmaceuticals Ltd
₹821
(₹105.57 per unit)
Alcohol
Safe if prescribed
Limit alcohol intake, along with Eltropag 25 mg Tablet, to attain the maximum efficacy of Eltropag 25 mg Tablet and rule out any possibility of worsening of side effects.
Pregnancy
Consult your doctor
Eltropag 25 mg Tablet is not recommended in pregnancy. It may affect and harm the developing baby. Please consult your doctor if you are pregnant or planning to conceive.
Breast Feeding
Consult your doctor
It is not known if Eltropag 25 mg Tablet is excreted into the breast milk. Please consult your doctor for more information before taking Eltropag 25 mg Tablet if you are a nursing mother.
Driving
Safe if prescribed
Eltropag 25 mg Tablet may cause dizziness and tiredness affecting your ability to concentrate and drive. Hence, it is recommended not to drive or operate machinery until you are mentally alert.
Liver
Consult your doctor
Let your doctor know if you have any history of liver diseases before taking Eltropag 25 mg Tablet. Eltropag 25 mg Tablet may cause an increase in liver enzymes. Your doctor may start the treatment with a lower dose of Eltropag 25 mg Tablet.
Kidney
Consult your doctor
Eltropag 25 mg Tablet should be used with caution in cases of renal impairment. It is advised to seek doctor advice before starting Eltropag 25 mg Tablet if you have any kidney problems.
Children
Safe if prescribed
Eltropag 25 mg Tablet is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Heart
Please inform your doctor if you have a history of heart disease before using Eltropag 25 mg Tablet. Your doctor will prescribe it only if the benefits outweigh the risks.
Geriatrics
Consult your doctor
Eltropag 25 mg Tablet is safe for use in elderly patients if prescribed by the physician.
Eltropag 25 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. It is also used to treat severe aplastic anemia (SAA) in adults.
Eltropag 25 mg Tablet contains Eltrombopag that stimulates platelet's production (helps in clotting) from megakaryocytes (bone marrow cells). Thus Eltropag 25 mg Tablet lowers the risk of bleeding episodes in diseases like immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA).
Do not stop using Eltropag 25 mg Tablet even if you feel better. It should be strictly used as advised by your doctor to avoid the recurrence of symptoms and worsening of the disease.
Eltropag 25 mg Tablet should be used with caution and only under doctor's supervision in cases of any allergic reactions, blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases.
Eltropag 25 mg Tablet decreases the risk of bleeding by increasing the platelet count in your body. However, you are advised to stay away from activities that may increase your risk of bleeding like contact sports and using sharp objects like razors and nail cutters.
It is advised to take Eltropag 25 mg Tablet on an empty stomach. Please take Eltropag 25 mg Tablet at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltropag 25 mg Tablet.
Eltropag 25 mg Tablet should be swallowed whole. Do not chew or crush the tablets.
It is usually taken once a day on an empty stomach, at least 1 hour before or 2 hours after eating. Take Eltropag 25 mg Tablet at around the same time every day.
It may take up to 2 weeks for patients to respond to Eltropag 25 mg Tablet.
Eltropag 25 mg Tablet should not be taken with foods, beverages, or other medicines that contain high concentrations of aluminium, calcium, iron, magnesium, selenium and zinc.
Eltropag 25 mg Tablet should be stored in a cool and dry place away from sunlight. Keep out of sight and reach of children.
Eltropag 25 mg Tablet can cause or increase the risk of severe liver issues. Check with your doctor straight away if you or your child experience nausea or vomiting, dark urine, light-coloured stools, right upper stomach pain, unusual exhaustion, or yellow eyes or skin while taking this medication.
Please take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule.
Country of origin
We provide you with authentic, trustworthy and relevant information